ONESOURCE
ONESOURCE SPECL PHARMA LHealthcare
LTP
1,576
CHG · %
+18.9 (+1.21%)
VOL · TODAY
1.52L
PREV CLOSE
1,557.1
Today's range1,545 · 1,586
1,576
52-week range1,057 · 1,925.8
1,576
Loading candles…
OneSource Specialty Pharma Ltd, incorporated in 2007, operates in the pharmaceutical, biologics, and contract development and manufacturing sectors. The company specializes in the research, development, manufacture, and commercialization of biological drug products presented in various injectable formats. It provides comprehensive contract development and manufacturing organization (CDMO) services covering all phases of pre-clinical and clinical development, as well as commercial supply of biologics and other pharmaceutical products. Formed through the consolidation of the softgel business of Strides Pharma Science, the sterile injectables business of SteriScience, and the biopharma business of Stelis Biopharma, OneSource is a multimodal pure-play specialty pharmaceutical CDMO. Its offerings span advanced technology platforms and therapeutic modalities, including biologics, drug-device combinations, sterile injectables, and oral technologies.
This page is a live market overview for ONESOURCE SPECL PHARMA L (ONESOURCE) on the NSE. As a listed security, ONESOURCE SPECL PHARMA L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ONESOURCE before placing trades on tick2trade.
As of the latest feed, ONESOURCE last traded at ₹1,576 on NSE, up ₹18.9 (1.21%) from the previous close of ₹1,557.1. Today's session range is ₹1,545 – ₹1,586, against a 52-week band of ₹1,057 – ₹1,925.8. Traded volume today stands at 1.52L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ONESOURCE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ONESOURCE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ONESOURCE SPECL PHARMA L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ONESOURCE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ONESOURCE option chain page linked from this overview.
// similar in healthcare314 total